Trademark: 97796233
Word
RESOLIAN BIOANALYTICS
Status
Pending
Status Code
819
Status Date
Tuesday, April 30, 2024
Serial Number
97796233
Mark Type
4
Filing Date
Wednesday, February 15, 2023
Published for Opposition
Tuesday, January 9, 2024

Trademark Owner History
Alliance Pharma Inc. - Owner At Publication

Classifications
42 Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical, bioanalytical, biological and biotechnology research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Pharmaceutical drug development services; Scientific testing in the fields of oncology, neurology, gastroenterology, immunology, endocrinology, gene therapy, infectious disease, rare and orphan diseases, cardiovascular disease, metabolic disease, central nervous system, ophthalmology, and respiratory diseases, for medical and pharmaceutical research purposes; Drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; Scientific analytical laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development
RESOLIAN BIO ANALYTICS
"BIOANALYTICS"

Trademark Events
Feb 18, 2023
New Application Entered
Mar 6, 2023
New Application Office Supplied Data Entered
Nov 14, 2023
Assigned To Examiner
Nov 14, 2023
Non-Final Action Written
Nov 14, 2023
Non-Final Action E-Mailed
Nov 14, 2023
Notification Of Non-Final Action E-Mailed
Nov 28, 2023
Teas Response To Office Action Received
Nov 28, 2023
Correspondence Received In Law Office
Nov 29, 2023
Teas/Email Correspondence Entered
Dec 2, 2023
Approved For Pub - Principal Register
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Jan 9, 2024
Published For Opposition
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2024
Noa E-Mailed - Sou Required From Applicant
Apr 1, 2024
Use Amendment Filed
Apr 1, 2024
Teas Statement Of Use Received
Apr 19, 2024
Case Assigned To Intent To Use Paralegal
Apr 19, 2024
Statement Of Use Processing Complete
Apr 30, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 30, 2024
Allowed Principal Register - Sou Accepted

Trademark Alertz updated from USPTO on 2030-01-24